The Magnitude and Time Course of Vecuronium Potentiation by Desflurane Versus Isoflurane

Background Preliminary studies suggest that desflurane and isoflurane potentiate the action of muscle relaxants equally. However, variability between subjects may confound these comparisons. A crossover study was performed in volunteers on the ability of desflurane and isoflurane to potentiate the neuromuscular effect of vecuronium, to influence its duration of action, and on the magnitude and time course of reversal of potentiation when anesthesia was withdrawn. Methods Adductor pollicis twitch tension was monitored in 16 volunteers given 1.25 MAC desflurane on one occasion, and 1.25 MAC isoflurane on another. In eight subjects, vecuronium bolus dose potency was determined using a two‐dose dose‐response technique; the vecuronium infusion dose requirement to achieve 85% twitch depression also was determined. Also in these subjects, the magnitude and time course of spontaneous neuromuscular recovery were determined when the anesthetic was withdrawn while maintaining a constant vecuronium infusion. In the other eight subjects, the time course of action of 100 micro gram/kg vecuronium was determined. Results Vecuronium's ED50 and infusion requirement to maintain 85% twitch depression were 20% less during desflurane, compared to isoflurane, anesthesia; vecuronium plasma clearance was similar during the two anesthetics. After 100 micro gram/kg vecuronium, onset was faster and recovery was longer during desflurane anesthesia. When the end‐tidal anesthetic concentration was abruptly reduced from 1.25 to 0.75 MAC, twitch tension increased similarly ([nearly equal] 15% of control), and time for the twitch tension to reach 90% of the final change was similar ([nearly equal] 30 min) with both anesthetics. Decreasing anesthetic concentration from 0.75 to 0.25 MAC increased twitch tension by 46 plus/minus 10% and 25 plus/minus 7% of control (mean plus/minus SD, P < 0.001) with desflurane and isoflurane, respectively; 90% response times for these changes were 31 plus/minus 10 min and 18 plus/minus 7 min (P < 0.05), respectively. Conclusions Desflurane potentiates the effect of vecuronium approximately 20% more than does an equipotent dose of isoflurane.

[1]  Ronald D. Miller,et al.  Onset and Duration of Rocuronium and Succinylcholine at the Adductor Pollicis and Laryngeal Adductor Muscles in Anesthetized Humans , 1994, Anesthesiology.

[2]  R. Miller,et al.  The pharmacodynamics and pharmacokinetics of the metabolite 3-desacetylvecuronium (ORG 7268) and its parent compound, vecuronium, in human volunteers. , 1994, The Journal of pharmacology and experimental therapeutics.

[3]  M. Sharma,et al.  Cumulative Characteristics of Atracurium and Vecuronium: A Simultaneous Clinical and Pharmacokinetic Study , 1994, Anesthesiology.

[4]  Ronald D. Miller,et al.  Comparison of Rocuronium, Succinylcholine, and Vecuronium for Rapid‐sequence Induction of Anesthesia in Adult Patients , 1993, Anesthesiology.

[5]  M. Zornow,et al.  Tracheal Intubation Without the Use of Muscle Relaxants: A Technique Using Propofol and Varying Doses of Alfentanil , 1992, Anesthesia and analgesia.

[6]  W. Kwan,et al.  Desflurane potentiates atracurium in humans: a comparative study with isoflurane. , 1992, Journal of clinical anesthesia.

[7]  Eger Ei nd Desflurane animal and human pharmacology: aspects of kinetics, safety, and MAC. , 1992 .

[8]  M. Seraj,et al.  Pipecuronium‐Induced Neuromuscular Blockade During Nitrous Oxide‐Fentanyl, Enflurane, Isoflurane, and Halothane Anesthesia in Surgical Patients , 1992, Anesthesia and analgesia.

[9]  P. White,et al.  Comparative effects of desflurane and isoflurane on vecuronium-induced neuromuscular blockade. , 1992, Journal of clinical anesthesia.

[10]  D. R. Cook,et al.  Vecuronium infusion requirements in children during halothane-narcotic-nitrous oxide, isoflurane-narcotic-nitrous oxide, and narcotic-nitrous oxide anesthesia. , 1991, Anesthesia and analgesia.

[11]  C. Lennmarken,et al.  The effect of peripheral hypothermia on a vecuronium‐induced neuromuscular block , 1991, Acta anaesthesiologica Scandinavica.

[12]  R. Weiskopf,et al.  The neuromuscular effects of desflurane, alone and combined with pancuronium or succinylcholine in humans. , 1991, Anesthesiology.

[13]  R. Weiskopf,et al.  Kinetics of desflurane, isoflurane, and halothane in humans. , 1991, Anesthesiology.

[14]  C. Mélot,et al.  Effects of residual concentrations of isoflurane on the reversal of vecuronium-induced neuromuscular blockade. , 1991, Anesthesiology.

[15]  E. Eger,et al.  Solubility of I-653, sevoflurane, isoflurane, and halothane in human tissues. , 1989, Anesthesia and analgesia.

[16]  O. Meretoja,et al.  Two-dose technique to create an individual dose-response curve for atracurium. , 1989, Anesthesiology.

[17]  C. Shanks,et al.  Dose-response relationships of doxacurium chloride in humans during anesthesia with nitrous oxide and fentanyl, enflurane, isoflurane, or halothane. , 1989, Anesthesiology.

[18]  R. Miller,et al.  Quantitation of pancuronium, 3-desacetylpancuronium, vecuronium, 3-desacetylvecuronium, pipecuronium and 3-desacetylpipecuronium in biological fluids by capillary gas chromatography using nitrogen-sensitive detection. , 1988, Journal of chromatography.

[19]  Ronald D. Miller,et al.  Continuous Infusion of Vecuronium: The Effect of Anesthetic Agents , 1987, Anesthesiology.

[20]  G. Volgyesi,et al.  SEVOFLURANE IN HEWBORN SWINEANESTHETIC REQUIREMENTS (MAC) AND CIRCULATORY RESPONSES , 1987 .

[21]  R. Lefebvre,et al.  Neostigmine antagonism of vecuronium paralysis during fentanyl, halothane, isoflurane, and enflurane anesthesia , 1985 .

[22]  R. Miller,et al.  Vecuronium‐induced Neuromuscular Blockade during Enflurane, Isoflurane, and Halothane Anesthesia in Humans , 1984, Anesthesiology.

[23]  E. Eger,et al.  Decreasing Enflurane Concentrations and d‐Tubocurarine Neuromuscular Blockade , 1982, Anesthesiology.

[24]  L. Sheiner,et al.  Pharmacokinetics and Pharmacodynamics of d-Tubocurarine during Nitrous Oxide–Narcotic and Halothane Anesthesia in Man , 1979 .

[25]  R. Elashoff,et al.  Minimum alveolar concentrations (MAC) of isoflurande with and without nitrous oxide in patients of various ages. , 1975, Anesthesiology.